TREA

86942598 - OSE IMMUNOTHERAPEUTICS

Follow

Information

  • Trademark
  • 86942598
  • Serial Number
    86942598
  • Registration Number
    5320086
  • Filing Date
    March 16, 2016
    8 years ago
  • Registration Date
    October 31, 2017
    7 years ago
  • Transaction Date
    December 31, 2024
    a month ago
  • Status Date
    October 25, 2024
    3 months ago
  • Published for Opposition Date
    August 15, 2017
    7 years ago
  • Location Date
    October 25, 2024
    3 months ago
Information
Mark Drawing Code
4
Mark Identification
OSE IMMUNOTHERAPEUTICS
Case File Statements
  • GS0051: Pharmaceutical products [ in the nature of chemicals ] for cancer treatment, oncology and immunotherapy; [ sanitary preparations for medical purposes; ] pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy [ for auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Substances for medicinal use, namely, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; Vaccines for treating cancer; vaccines; Substances for medicinal use, namely, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts ]
  • PM0001: ORPHAN SYNERGY EUROPE IMMUNE THERAPEUTICS
  • GS0441: [ Medical services ]
  • DS0000: "IMMUNOTHERAPEUTICS"
  • GS0421: [ Scientific and technological services, namely, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others ]
Case File Event Statements
  • 3/23/2016 - 8 years ago
    4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/19/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/21/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/22/2016 - 8 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 3/23/2016 - 8 years ago
    5 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 6/27/2016 - 8 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/6/2016 - 8 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/6/2016 - 8 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/6/2016 - 8 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/3/2016 - 8 years ago
    10 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/20/2016 - 8 years ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/20/2016 - 8 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/24/2016 - 8 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/24/2016 - 8 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/24/2016 - 8 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/25/2016 - 8 years ago
    16 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/25/2016 - 8 years ago
    17 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 11/25/2016 - 8 years ago
    18 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/10/2017 - 7 years ago
    19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/10/2017 - 7 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/10/2017 - 7 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/8/2017 - 7 years ago
    22 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/8/2017 - 7 years ago
    24 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 6/2/2017 - 7 years ago
    26 - ASSIGNED TO LIE Type: ALIE
  • 6/8/2017 - 7 years ago
    27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/8/2017 - 7 years ago
    28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/6/2017 - 7 years ago
    29 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/26/2017 - 7 years ago
    30 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/15/2017 - 7 years ago
    31 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/15/2017 - 7 years ago
    32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/31/2017 - 7 years ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/31/2022 - 2 years ago
    34 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 4/30/2024 - 9 months ago
    35 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 5/8/2017 - 7 years ago
    23 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/8/2017 - 7 years ago
    25 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/23/2024 - 3 months ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/23/2024 - 3 months ago
    37 - POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Type: PR23
  • 10/25/2024 - 3 months ago
    38 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 10/25/2024 - 3 months ago
    39 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 10/25/2024 - 3 months ago
    40 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85